Ultrasound mediated delivery of quantum dots from a proof of concept capsule endoscope to the gastrointestinal wall

Stewart, F. et al. (2021) Ultrasound mediated delivery of quantum dots from a proof of concept capsule endoscope to the gastrointestinal wall. Scientific Reports, 11, 2584. (doi: 10.1038/s41598-021-82240-1) (PMID:33510366) (PMCID:PMC7844260)

[img] Text
232848.pdf - Published Version
Available under License Creative Commons Attribution.



Biologic drugs, defined as therapeutic agents produced from or containing components of a living organism, are of growing importance to the pharmaceutical industry. Though oral delivery of medicine is convenient, biologics require invasive injections because of their poor bioavailability via oral routes. Delivery of biologics to the small intestine using electronic delivery with devices that are similar to capsule endoscopes is a promising means of overcoming this limitation and does not require reformulation of the therapeutic agent. The efficacy of such capsule devices for drug delivery could be further improved by increasing the permeability of the intestinal tract lining with an integrated ultrasound transducer to increase uptake. This paper describes a novel proof of concept capsule device capable of electronic application of focused ultrasound and delivery of therapeutic agents. Fluorescent markers, which were chosen as a model drug, were used to demonstrate in vivo delivery in the porcine small intestine with this capsule. We show that the fluorescent markers can penetrate the mucus layer of the small intestine at low acoustic powers when combining microbubbles with focused ultrasound during in vivo experiments using porcine models. This study illustrates how such a device could be potentially used for gastrointestinal drug delivery and the challenges to be overcome before focused ultrasound and microbubbles could be used with this device for the oral delivery of biologic therapeutics.

Item Type:Articles
Additional Information:Financial support is gratefully acknowledged from the UK Engineering and Physical Sciences Research Council (EPSRC), Grant EP/K034537 (Sonopill Programme), and the Biotechnology and Biological Sciences Research Council (BBSRC), Grant BB/M017079/1.
Glasgow Author(s) Enlighten ID:Turcanu, Mihnea and Cox, Dr Benjamin F and Cochran, Professor Sandy
Authors: Stewart, F., Cummins, G., Turcanu, M. V., Cox, B. F., Prescott, A., Clutton, E., Newton, I. P., Desmulliez, M. P. Y., Thanou, M., Mulvana, H., Cochran, S., and Näthke, I.
College/School:College of Science and Engineering > School of Engineering > Systems Power and Energy
Journal Name:Scientific Reports
Publisher:Nature Research
ISSN (Online):2045-2322
Copyright Holders:Copyright © 2021 The Authors
First Published:First published in Scientific Reports 11:2584
Publisher Policy:Reproduced Under A Creative Commons Licence

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
169106Sonopill: minimally invasive gastrointestinal diagnosis and therapyDavid CummingEngineering and Physical Sciences Research Council (EPSRC)EP/K034537/1ENG - Electronics & Nanoscale Engineering
173138Sonopill: minimally invasive gastrointestinal diagnosis and therapyAlexander CochranEngineering and Physical Sciences Research Council (EPSRC)EP/K034537/2ENG - Systems Power & Energy